48.41
前日終値:
$48.11
開ける:
$48.83
24時間の取引高:
23.97M
Relative Volume:
0.66
時価総額:
$10.54B
収益:
$1.78B
当期純損益:
$164.40M
株価収益率:
70.16
EPS:
0.69
ネットキャッシュフロー:
$236.51M
1週間 パフォーマンス:
+14.31%
1か月 パフォーマンス:
-12.81%
6か月 パフォーマンス:
+18.39%
1年 パフォーマンス:
+235.48%
Hims Hers Health Inc Stock (HIMS) Company Profile
名前
Hims Hers Health Inc
電話
415-851-0195
住所
2269 CHESTNUT ST, SAN FRANCISCO
HIMS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HIMS
Hims Hers Health Inc
|
48.41 | 10.87B | 1.78B | 164.40M | 236.51M | 0.69 |
![]()
PG
Procter Gamble Co
|
160.02 | 372.88B | 84.28B | 16.07B | 14.05B | 6.51 |
![]()
UL
Unilever Plc Adr
|
64.31 | 159.40B | 64.99B | 6.71B | 6.53B | 2.4495 |
![]()
CL
Colgate Palmolive Co
|
85.13 | 67.62B | 20.00B | 3.05B | 3.37B | 3.56 |
![]()
KMB
Kimberly Clark Corp
|
129.89 | 42.86B | 18.88B | 2.38B | 2.10B | 7.26 |
![]()
KVUE
Kenvue Inc
|
18.62 | 39.42B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-23 | ダウングレード | Needham | Buy → Hold |
2025-06-04 | 繰り返されました | Needham | Buy |
2025-04-29 | ダウングレード | TD Cowen | Buy → Hold |
2025-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2025-01-10 | ダウングレード | Citigroup | Neutral → Sell |
2025-01-07 | 開始されました | BTIG Research | Buy |
2024-12-17 | 開始されました | Morgan Stanley | Overweight |
2024-11-14 | ダウングレード | BofA Securities | Buy → Underperform |
2024-08-22 | 開始されました | Needham | Buy |
2024-08-09 | ダウングレード | Imperial Capital | Outperform → In-line |
2024-05-22 | ダウングレード | Citigroup | Buy → Neutral |
2024-04-16 | ダウングレード | Jefferies | Buy → Hold |
2024-04-10 | 開始されました | Canaccord Genuity | Buy |
2024-02-28 | アップグレード | Imperial Capital | In-line → Outperform |
2024-02-26 | 開始されました | Leerink Partners | Market Perform |
2023-12-07 | 開始されました | Imperial Capital | In-line |
2023-07-28 | 開始されました | TD Cowen | Outperform |
2023-04-11 | 開始されました | Robert W. Baird | Neutral |
2023-02-09 | アップグレード | Jefferies | Hold → Buy |
2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
2022-09-07 | 開始されました | Truist | Hold |
2022-07-15 | 開始されました | SVB Leerink | Underperform |
2022-04-14 | 開始されました | Guggenheim | Buy |
2022-04-01 | 再開されました | Credit Suisse | Outperform |
2022-03-10 | 開始されました | Deutsche Bank | Hold |
2021-12-02 | 開始されました | Jefferies | Hold |
2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-07-06 | 開始されました | BofA Securities | Neutral |
2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
2021-04-21 | 開始されました | Truist | Hold |
2021-03-09 | 開始されました | Credit Suisse | Neutral |
2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
2021-02-17 | 開始されました | Citigroup | Neutral |
2021-02-12 | 開始されました | Piper Sandler | Neutral |
2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Hers Health Inc. is moving todayNew Guidance & Accurate Buy Signal Notifications - Newser
Hims & Hers Health Stock Surges Amid Expansion - TipRanks
Hims & Hers Health signs 15-year lease for Ohio facility with $5.98 million annual rent - Investing.com Canada
Hims & Hers Health: Pioneering the Future of Digital Healthcare Amid Secular Megatrends - AInvest
Hims & Hers Health: At The Intersection Of Secular Megatrends (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Expands with New Ohio Facility - TipRanks
Hers Health Inc. in sector analysisInsider Selling & Weekly Top Gainers Trade List - Newser
Hers Health Inc. stock trendline breakdown2025 Trading Recap & Low Risk High Reward Ideas - Newser
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms - Insider Monkey
Hims & Hers Health: A Disruptive Force in Personalized Digital Healthcare and Its Implications for Long-Term Growth - AInvest
Exclusive: Remedy Meds to acquire Thirty Madison - Axios
Why Hims & Hers Health (HIMS) Stock Is Up Today - TradingView
Sustainable weight loss with Hims & Hers - fox10tv.com
Experts discuss the impact of limited insurance coverage on obesity treatment access - KOKH
BofA Securities maintains Underperform rating on Hims and Hers stock By Investing.com - Investing.com Australia
BofA Securities maintains Underperform rating on Hims and Hers stock - Investing.com
4 Top Stocks to Buy in September - The Motley Fool
HIMS Stock Climbs 7% after Eli Lilly’s Knockoff Case Falls Flat - TipRanks
Navigating the Storm: Hims & Hers' Legal Resilience in the Telehealth and Compounded Drug Sector - AInvest
Eli Lillys 036 Gains Overshadowed by 3075 Volume Drop as Court Dismisses Lawsuit Stock Ranks 33rd in Market Activity Amid Hims Surge - AInvest
Strategic Capital Moves in Disruptive Consumer & Mobility Sectors: Lyft, Hims & Hers, and Constellation Brands - AInvest
Noteworthy Wednesday Option Activity: HIMS, UNH, SMMT - Nasdaq
Lyft convertible notes, Hims & Hers surges, Constellation Brands - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Innovation and Recent Setbacks - Quiver Quantitative
Hims & Hers gains after court rejects Eli Lilly’s case against Willow - Yahoo Finance
Hims & Hers Health Set to Meet Revenue Projections Amid Growing Confidence - StocksToTrade
Hims & Hers Sees Revenue Growth Amid Deutsche Bank’s Optimistic Outlook - timothysykes.com
Hers Health Inc.Weekly Market Report & Community Consensus Picks - Newser
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS' Personalized Wellness Platform Expands Preventive Care Access - sharewise.com
Hers Health Inc. holdersEarnings Overview Report & Daily Stock Trend Reports - Newser
Hers Health Inc. reversing from oversold territoryLayoff News & Accurate Buy Signal Notifications - Newser
Hims & Hers Health: Still Undervalued (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. stock trend forecastRisk Management & Reliable Volume Spike Trade Alerts - Newser
Hers Health Inc. bounce back from current support2025 Price Targets & AI Enhanced Trading Signals - Newser
Insider Moves: Datadog, Hims & Hers, Opendoor, Texas Instruments, Vertiv - TipRanks
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Climbs to 102nd in Market Activity With $790M Volume as Insider Sales and Mixed Earnings Spark Doubts - AInvest
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims & Hers Health Stock Plunges 2.95% as Trading Volume Falls 32% to $890M and Drops to 67th in Activity - AInvest
Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):